טוען...
Strategies to Improve the Clinical Outcomes for Direct-to-Consumer Pharmacogenomic Tests
Direct-to-consumer genetic tests (DTC-GT) have become a bridge between marketing and traditional healthcare services. After earning FDA endorsement for such facilities, several fast-developing companies started to compete in the related area. Pharmacogenomic (PGx) tests have been introduced as poten...
שמור ב:
| הוצא לאור ב: | Genes (Basel) |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
MDPI
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7999840/ https://ncbi.nlm.nih.gov/pubmed/33802585 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/genes12030361 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|